KEGG   DRUG: Darunavir and cobicistat
Entry
D10832            Mixture   Drug                                   
Name
Darunavir and cobicistat;
Prezcobix (TN);
Rezolsta (TN)
  Abbr
DRV/c
Product
Component
(Darunavir ethanolate [DR:D06478] | Darunavir [DR:D03656]), Cobicistat [DR:D09881]
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
Therapeutic category: 6250
ATC code: J05AR14
Product: D10832<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV protease [KO:K22599]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR14 Darunavir and cobicistat
      D10832  Darunavir and cobicistat <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Darunavir/ Cobicistat
    D10832  Darunavir and cobicistat
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10832  Darunavir and cobicistat
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D10832  Darunavir and cobicistat
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D10832  Darunavir and cobicistat
Antimicrobials [BR:br08307]
 Antivirals
  Polyprotein cleavage inhibitor
   HIV protease inhibitor
    D10832  Darunavir and cobicistat <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10832
Other DBs
PubChem: 319902632
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system